-
公开(公告)号:US20180339060A1
公开(公告)日:2018-11-29
申请号:US16053344
申请日:2018-08-02
Applicant: PFIZER INC.
Inventor: Andreas MADERNA , Matthew David DOROSKI , Zecheng CHEN , Hud Lawrence RISLEY , Jeffrey Michael CASAVANT , Christopher John O'DONNELL , Alexander M. PORTE , Chakrapani SUBRAMANYAM
IPC: A61K47/68 , C07K9/00 , C07K5/06 , C07H17/02 , C07F9/6561 , C07D487/04 , C07D417/14 , C07D409/14 , C07D405/14 , C07D401/14 , A61K38/06 , A61K38/05 , A61K31/7056 , A61K31/675 , A61K31/454 , A61K31/4439 , A61K31/433 , A61K31/407 , A61K31/404 , C07K5/08
CPC classification number: A61K47/6851 , A61K31/404 , A61K31/407 , A61K31/433 , A61K31/4439 , A61K31/454 , A61K31/675 , A61K31/7056 , A61K38/05 , A61K38/06 , A61K47/6803 , A61K47/6807 , A61K47/6811 , C07D401/14 , C07D405/14 , C07D409/14 , C07D417/14 , C07D487/04 , C07F9/6561 , C07H17/02 , C07K5/06 , C07K5/08 , C07K9/003
Abstract: Cytotoxic dimers comprising CBI-based and/or CPI-based sub-units, antibody drug conjugates comprising such dimers, and to methods for using the same to treat cancer and other conditions.
-
公开(公告)号:US20150209445A1
公开(公告)日:2015-07-30
申请号:US14605697
申请日:2015-01-26
Applicant: Pfizer Inc.
Inventor: Andreas MADERNA , Matthew David DOROSKI , Zecheng CHEN , Hud Lawrence RISLEY , Jeffrey Michael CASAVANT , Christopher John O'DONNELL , Alexander M. PORTE , Chakrapani SUBRAMANYAM
IPC: A61K47/48 , A61K31/404 , A61K31/4439 , C07D401/14 , C07D409/14 , A61K31/675 , C07F9/6561 , A61K31/454 , A61K31/7056 , C07H17/02 , C07D417/14 , A61K31/433 , A61K31/407 , C07D487/04 , C07K5/08 , C07K5/06 , C07K9/00 , A61K38/05 , A61K38/06 , C07D405/14
CPC classification number: A61K47/48384 , A61K31/404 , A61K31/407 , A61K31/433 , A61K31/4439 , A61K31/454 , A61K31/675 , A61K31/7056 , A61K38/05 , A61K38/06 , A61K47/6803 , A61K47/6807 , A61K47/6811 , C07D401/14 , C07D405/14 , C07D409/14 , C07D417/14 , C07D487/04 , C07F9/6561 , C07H17/02 , C07K5/06 , C07K5/08 , C07K9/003
Abstract: Cytotoxic dimers comprising CBI-based and/or CPI-based sub-units, antibody drug conjugates comprising such dimers, and to methods for using the same to treat cancer and other conditions.
Abstract translation: 包含基于CBI和/或CPI的亚单位的细胞毒性二聚体,包含这种二聚体的抗体药物偶联物,以及使用该二聚体治疗癌症和其它病症的方法。
-
公开(公告)号:US20130129753A1
公开(公告)日:2013-05-23
申请号:US13670612
申请日:2012-11-07
Applicant: PFIZER INC.
Inventor: Matthew David DOROSKI , Andreas MADERNA , Christopher John O'DONNELL , Chakrapani SUBRAMANYAM , Beth VETELINO , Russell George DUSHIN , Pavel STROP , Edmund Idris GRAZIANI
CPC classification number: C07K7/06 , A61K38/06 , A61K38/07 , A61K38/08 , A61K47/6803 , A61K47/6811 , A61K47/6851 , A61K47/6855 , A61K47/6863 , A61K47/6889 , C07K5/0205 , C07K5/0808 , C07K7/02 , C07K16/00 , C07K2319/30
Abstract: The present invention is directed to cytotoxic pentapeptides, to antibody drug conjugates thereof, and to methods for using the same to treat cancer.
-
4.
公开(公告)号:US20150307551A1
公开(公告)日:2015-10-29
申请号:US14793942
申请日:2015-07-08
Applicant: PFIZER INC.
Inventor: Matthew David DOROSKI , Andreas MADERNA , Christopher John O'DONNELL , Chakrapani SUBRAMANYAM , Beth VETELINO , Russell George DUSHIN , Pavel STROP , Edmund Idris GRAZIANI
IPC: C07K7/06
CPC classification number: C07K7/06 , A61K38/06 , A61K38/07 , A61K38/08 , A61K47/6803 , A61K47/6811 , A61K47/6851 , A61K47/6855 , A61K47/6863 , A61K47/6889 , C07K5/0205 , C07K5/0808 , C07K7/02 , C07K16/00 , C07K2319/30
Abstract: The present invention is directed to cytotoxic pentapeptides, to antibody drug conjugates thereof, and to methods for using the same to treat cancer.
Abstract translation: 本发明涉及细胞毒性五肽,其抗体药物偶联物及其用于治疗癌症的方法。
-
公开(公告)号:US20140363452A1
公开(公告)日:2014-12-11
申请号:US14322262
申请日:2014-07-02
Applicant: PFIZER INC.
Inventor: Matthew David DOROSKI , Andreas MADERNA , Christopher John O'DONNELL , Chakrapani SUBRAMANYAM , Beth VETELINO , Russell George DUSHIN , Pavel STROP , Edmund Idris GRAZIANI
CPC classification number: C07K7/06 , A61K38/06 , A61K38/07 , A61K38/08 , A61K47/6803 , A61K47/6811 , A61K47/6851 , A61K47/6855 , A61K47/6863 , A61K47/6889 , C07K5/0205 , C07K5/0808 , C07K7/02 , C07K16/00 , C07K2319/30
Abstract: The present invention is directed to cytotoxic pentapeptides, to antibody drug conjugates thereof, and to methods for using the same to treat cancer.
Abstract translation: 本发明涉及细胞毒性五肽,其抗体药物偶联物及其用于治疗癌症的方法。
-
-
-
-